Pulmonary aspergillosis has been increasingly reported following severe respiratory viral
infections. Millions have been infected by SARS-CoV-2, placing large numbers of patients at …

Invasive pulmonary aspergillosis (IPA) is increasingly recognized as a life-threatening
superinfection of severe respiratory viral infections, such as influenza. The pandemic of …

First reports of cases and case series of COVID-19-associated pulmonary aspergillosis
(CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely …

Objectives Information on the recently COVID‐19‐associated pulmonary aspergillosis
(CAPA) entity is scarce. We describe eight CAPA patients, compare them to colonised ICU …

Background Invasive aspergillosis is a well‐known complication of severe influenza
pneumonia with acute respiratory distress syndrome (ARDS). However, recent studies are …

The devastating pandemia of the novel Coronavirus Disease 2019 (COVID-19) resulting
from the emergence of SARS-CoV-2 is of particular concern because of the development of …

In this systematic review, we investigate the epidemiology, pathogenesis, risk factors, clinical
manifestations, diagnosis and treatment of COVID-19-associated pulmonary aspergillosis …

The coronavirus disease 2019 (COVID-19) virus caused a wide spectrum of disease in
healthy individuals, as well as those with common comorbidities [1]. Severe COVID-19 is …

Invasive pulmonary aspergillosis (IPA) has always been a challenging diagnosis and risk
factors an important guide to investigate specific population, especially in Intensive Care …

Like severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory
distress syndrome (ARDS) has emerged as an important disease that predisposes patients …